The global pain management devices market, valued at US$3491.0 million in 2023, stood at US$3,768.6 million in 2024 and is projected to advance at a resilient CAGR of 9.1% from 2024 to 2029, culminating in a forecasted valuation of US$5,835.8 million by the end of the period.
Chronic pain affects millions worldwide, driving demand for innovative, non-opioid therapies that improve quality of life. From spinal cord stimulators (SCS) and neurostimulation platforms to radiofrequency ablation (RFA) systems and wearable pain-relief technologies, the pain management devices market is evolving rapidly. Industry leaders are investing heavily in AI-powered neuromodulation, minimally invasive therapies, and smart implantable systems to deliver more personalized treatment outcomes.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163
Here’s a look at the top 10 companies leading the global pain management devices industry in 2026.
1. Medtronic
Medtronic remains one of the most dominant players in pain management technology, particularly in spinal cord stimulation and neuromodulation. Its Intellis™, Vanta™, and Inceptiv™ systems are widely adopted for chronic pain treatment. The company recently gained attention for its FDA-approved closed-loop spinal cord stimulator capable of automatically adjusting stimulation in real time.
Key Strengths
- Advanced spinal cord stimulation platforms
- AI-driven pain therapy personalization
- Strong global hospital network
2. Boston Scientific
Boston Scientific is a global leader in neuromodulation and chronic pain therapies. Its WaveWriter™ and Spectra WaveWriter™ systems are among the most recognized SCS devices in the market. The company has expanded aggressively through acquisitions, including Nalu Medical, strengthening its peripheral nerve stimulation portfolio.
Key Strengths
- Multi-waveform neurostimulation technology
- Strong clinical evidence and physician adoption
- Expansion into peripheral nerve stimulation
Community discussions on Reddit also highlight long-term patient satisfaction with Boston Scientific stimulators, particularly regarding MRI compatibility and app-based controls.
3. Abbott
Abbott has built a strong presence in neuromodulation through its Proclaim™ spinal cord stimulation systems and RFA technologies. Abbott focuses heavily on minimally invasive pain therapies and integrated digital solutions. The company is also recognized for strong market share in radiofrequency ablation technologies.
Key Strengths
- Implantable neuromodulation systems
- Wireless and smartphone-controlled therapies
- Strong R&D investment
4. Nevro Corp.
Nevro Corp. specializes exclusively in chronic pain management solutions. Its HFX™ spinal cord stimulation platform is known for delivering paresthesia-free pain relief. The company continues to innovate with adaptive AI-enabled pain management technologies.
Key Strengths
- High-frequency spinal cord stimulation
- AI-enabled adaptive therapy
- Strong chronic pain specialization
5. Stryker
Stryker plays a significant role in interventional pain management through radiofrequency ablation technologies and minimally invasive systems. The company is increasingly expanding its chronic pain portfolio through partnerships and acquisitions.
Key Strengths
- Strong interventional pain solutions
- Advanced RFA systems
- Large orthopedic and surgical ecosystem
6. Avanos Medical
Avanos Medical is best known for its COOLIEF™ cooled radiofrequency therapy platform, designed for minimally invasive chronic pain treatment. The company focuses heavily on non-opioid pain therapies and outpatient pain management procedures.
Key Strengths
- Non-opioid chronic pain solutions
- Cooled radiofrequency ablation technology
- Strong outpatient procedure adoption
7. Baxter International
Baxter International offers infusion pumps and advanced pain management delivery systems widely used in hospitals and surgical centers. Its technologies support post-operative and chronic pain therapies globally.
Key Strengths
- Pain infusion systems
- Strong hospital presence
- Global healthcare infrastructure
8. B. Braun
B. Braun is recognized for infusion therapy and pain management delivery devices. The company provides epidural analgesia systems, infusion pumps, and regional anesthesia solutions across global healthcare facilities.
Key Strengths
- Infusion and analgesia expertise
- Strong European market presence
- Comprehensive hospital solutions
9. Zynex Medical
Zynex Medical focuses on non-invasive electrotherapy devices for pain management and rehabilitation. Its FDA-cleared TensWave device is gaining traction in home-based pain treatment.
Key Strengths
- Non-invasive electrotherapy systems
- Home-based pain management devices
- Growing rehabilitation market presence
10. Saluda Medical
Saluda Medical is known for its closed-loop spinal cord stimulation technology that automatically responds to patient neural signals. The company is emerging as a strong innovator in precision neuromodulation.
Key Strengths
- Closed-loop neuromodulation
- Personalized pain therapy
- Advanced sensing technology
Emerging Trends in the Pain Management Devices Market
AI-Driven Neuromodulation
Companies are integrating artificial intelligence into spinal cord stimulators to personalize therapy and improve patient outcomes.
Shift Toward Non-Opioid Therapies
Growing concerns about opioid dependence are accelerating demand for minimally invasive pain management devices.
Growth of Wearable & Home-Based Devices
Wearable electrotherapy and remote-controlled stimulation systems are expanding access to chronic pain treatment.
Expansion of Peripheral Nerve Stimulation
Peripheral nerve stimulation (PNS) technologies are becoming a major growth segment in chronic pain therapy.
Final Thoughts
The pain management devices market is entering a new era driven by smart neuromodulation, minimally invasive procedures, and personalized therapy systems. Companies like Medtronic, Boston Scientific, and Abbott continue to dominate through innovation and global reach, while emerging players like Saluda Medical and Nevro Corp. are redefining next-generation pain therapies.
As healthcare systems worldwide prioritize non-opioid chronic pain treatment, the industry is expected to witness rapid technological advancement and strong market growth over the next decade.
Request Free Sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91418163
